Leukocytosis as a Predictor of Clinical Worsening and Complications in Children with Pertussis: A Systematic Review of Case Study
https://doi.org/10.33860/jik.v17i1.2211
Keywords:
pertussis, clinical deterioration, pneumonia, leukocytosisAbstract
Pertussis is a highly contagious disease with clinical features ranging from mild to severe and various complications. Hematological examination, especially the leukocyte count, can predict the possibility of clinical deterioration with several complications, such as pneumonia. This case study aimed to assess whether leukocytosis could indicate the clinical worsening of pertussis in children. This research method is a systematic review on a case study. The subject of this case study is a child with pertussis experiencing clinical deterioration. Prominent laboratory data in this case study includes leukocytosis. This systematic review aims to analyze the association between leukocytosis and the clinical deterioration of this case study. Literature search procedure using PubMed, Cochrane, and Google Scholar search instruments. The keywords used are "pertussis," "risk factor," and "and children." Using the limitations of randomized controlled clinical trials, systematic reviews, meta-analyses, cohorts, and cross-sectional or case series, the language of instruction is English, and publications within the last 20 years. Overall, 16,666 articles were obtained, consisting of 43 pieces from PubMed; only two papers were valid. Of the 3,123 articles on the Cochrane, only two are valid. Likewise, out of 13,500 articles on Google Scholar, only two are valid. Furthermore, it was traced based on the aspect of duplication, then three papers were found, which were cohort studies. It was concluded that leukocytosis predicts clinical deterioration and complications in children with pertussis.
References
Nguyen VTN SL. Pertusis: the Whooping Cough. Prim Care. 2018;45(3):423–31.
Kang L, Cui X, Fu J, Wang W, Li L LT. Clinical characteristics of 967 children with pertussis: a single-center analysis over an 8-year period in Beijing, China. Eur J Clin Microbiol Infect Dis. 2021;
Shi T, Wang L, Du S, Fan H, Yu M, Ding T, et al. Mortality risk factors among hospitalized children with severe pertussis. BMC Infect Dis [Internet]. 2021 Dec 12;21(1):1057. Available from: https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-021-06732-1
Zamir CS, Dahan DB, Shoob H. Pertussis in infants under one year old: Risk markers and vaccination status—A case-control study. Vaccine [Internet]. 2015 Apr;33(17):2073–8. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0264410X1500239X
WHO. Bordetella pertussis/ Bordetella parapertussis. 2014;7–14.
Tao Y, Tang M, Luo L, Xiang L, Xia Y LB. Identification of etiologic agents and clinical characteristics for patients suspected of having pertussis in a large Children’s Hospital in China. Med. 2019;7(18):443.
Kapil P, Merkel TJ. Pertussis vaccines and protective immunity. Curr Opin Immunol [Internet]. 2019 Aug;59:72–8. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0952791518301237
Godoy P MCJ. The effect of Maternal pertusis vaccination on the Epidemiology of Pertusis in Spain. Enferm Infecc Microbiol Clin (Engl Ed). 2022;40(9):467–9.
Wu DX, Chen Q, Yao KH, Li L, Shi W, Ke JW, Wu AM, Huang P SK. Pertusis Detection in Children with Cough of Any Duration. BMC Pediatr. 2019;19(1):236.
González-Barcala FJ, Villar-Álvarez F MTF. Whooping Cough: the Visible Enemy. Arch Bronconeumol. Arch Bronconeumol. 2022;58(4):300–2.
Forsyth K, Plotkin S, Tan T W von KC. Strategies to Decrease pertusis transmission to Infant. Pediatrics. 2015;135(6):1475–82.
Monaco F, Barone M, Manfredi VG, Marando R, Nunnari F, David A, Monaco M CA. Pneummediastinum as a complication of critical pertusis. Clin Respir J. 2016;10(6):772–6.
Palvo F, Fabro AT, Cervi MC, Aragon DC, Ramalho FS CA de C. Severe pertussis infection: a clinicopathological study. Med. 2017;96(48):8823.
Mohammadzadeh Asl Y, Akhi MT, Soroush MH, Sefidan FY, Mousapour J HM. Clinical Manifestations and Seasonality of Pertussis in Azerbaijan, Iran. Infect Dis Clin Pr. 2018;26(3):145–9.
Gopal DP, Barber J, Toeg D. Pertussis (whooping cough). BMJ [Internet]. 2019 Feb 22;364. Available from: https://www.bmj.com/lookup/doi/10.1136/bmj.l401
Polinori I, Esposito S. Clinical Findings and Management of Pertussis. In 2019. p. 151–60. Available from: http://link.springer.com/10.1007/5584_2019_410
Zhang JS, Wang HM, Yao KH, Liu Y, Lei YL, Deng JK YY. Clinical Characteristics , moleculer epidemiology and antimicrobial suseptibility of Pertusis in Southern China. World J Pediatr. 2020;16(2):185–92.
Zhang J, Deng J YY. Pertusis Vaccination in Chinese Children with increasing Reported Pertusis Case. Lancet Infect Dis. 2022;22(1):21–2.
Levri KM, Reynolds L, Liko J, Dott M, Robinson BF CP. Risk Factors for Pertussis Among Hispanic Infants. Pediatr Infect Dis J. 2016;35(5):2010–2.
Kavitha TK, Samprathi M, Jayashree M, Gautam V SL. Clinical Profile of Critical Pertusis in Children at a Pediatric Intensive Care Unit in Nothern India. Indian Pediatr. 2020;15(57):228–31.
Deshmukh S, Magdalene D GK. Ocular manifestation of whooping cough in a vaccinated child. TNOA J Ophthalmic Sci Res. 2018;56(3):185.
Moore A, Harnden A, Grant CC, Patel S, Irwin RS AK. Clinically Diagnosing Pertussis-associated Cough in Adults and Children: CHEST Guideline and Expert Panel Report. Chest. 2019;115(1):147–54.
Macina D, Evans KE. Bordetella pertussis in School-Age Children, Adolescents, and Adults: A Systematic Review of Epidemiology, Burden, and Mortality in the Middle East. Infect Dis Ther [Internet]. 2021 Jun 27;10(2):719–38. Available from: https://link.springer.com/10.1007/s40121-021-00440-8
Decker MD EK. Pertussis (Whooping Cough). J Infect Dis. 2021;224(4):310–20.
Tian S F, Wong HM DJ. Fatal malignant pertussis with hyperleukocytosis in a Chinese infant: A case report and literature review. Medicine (Baltimore). 2019;97(17):1–4.
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with Poltekita : Jurnal Ilmu Kesehatan agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY-SA 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
This work is licensed under a Creative Commons Attribution-ShareAlike 2.0 Generic License.
Poltekita : Jurnal Ilmu Kesehatan is licensed under a Creative Commons Attribution-Share Alike 4.0 International License
You are free to:
- Share, copy and redistribute the material in any medium or format
- Adapt, remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
